The estimated Net Worth of Dennis E Condon is at least $369 Thousand dollars as of 22 March 2022. Mr. Condon owns over 9,000 units of Establishment Labs Inc stock worth over $368,910 and over the last 5 years he sold ESTA stock worth over $0. In addition, he makes $0 as Independent Director at Establishment Labs Inc.
Dennis has made over 3 trades of the Establishment Labs Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 9,000 units of ESTA stock worth $91,710 on 22 March 2022.
The largest trade he's ever made was exercising 9,000 units of Establishment Labs Inc stock on 22 March 2022 worth over $91,710. On average, Dennis trades about 2,455 units every 26 days since 2019. As of 22 March 2022 he still owns at least 9,000 units of Establishment Labs Inc stock.
You can see the complete history of Mr. Condon stock trades at the bottom of the page.
Dennis E. Condon serves as Independent Director of the Company. He was President and Chief Executive Officer of Merz Aethetics (formerly BioForm Medical) from July 2007 to January 2013. From March 2006 to May 2007, Mr. Condon was President and Chief Executive Officer of Aspara Medical, and was President and Chief Executive Officer of Reliant Technology from January 2005 to February 2006. Prior to joining Reliant Technology, Mr. Condon held various roles at Spa Medicus, The Plastic Surgery Company and Mentor Corporation. Mr. Condon has served on the Board of Directors of Suneva Medical since September 2016 and AirXpanders Inc from 2012 to July 2019. Mr. Condon holds a bachelor’s degree in Biological Science from University of California, Davis.
Dennis Condon is 83, he's been the Independent Director of Establishment Labs Inc since 2017. There are no older and 17 younger executives at Establishment Labs Inc.
Dennis's mailing address filed with the SEC is C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES, DE, 19958.
Over the last 6 years, insiders at Establishment Labs Inc have traded over $8,492,826 worth of Establishment Labs Inc stock and bought 169,894 units worth $9,905,657 . The most active insiders traders include David Hung, Nicholas Sheridan Lewin, and Quiros Juan Jose Chacon. On average, Establishment Labs Inc executives and independent directors trade stock every 34 days with the average trade being worth of $513,072. The most recent stock trade was executed by Quiros Juan Jose Chacon on 11 July 2024, trading 3,641 units of ESTA stock currently worth $163,991.
establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.
Establishment Labs Inc executives and other stock owners filed with the SEC include: